COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

BPF Genetics of ILD Study (BPF GILD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03747627
Recruitment Status : Recruiting
First Posted : November 20, 2018
Last Update Posted : January 18, 2020
University of Leicester
University of Glasgow
Newcastle University
British Lung Foundation
British Pigeon Fanciers Medical Research
Information provided by (Responsible Party):
Mark Spears, NHS Forth Valley

Brief Summary:
The investigators aim to examine the genetic determinants of interstitial lung disease in a cohort of subjects with regular exposure to pigeons, a known cause of one form of interstitial lung disease known as hypersensitivity pneumonitis. The investigators hope the investigator's work will provide insights of use to clinicians and patients with hypersensitivity pneumonitis and other interstitial lung diseases.

Condition or disease Intervention/treatment
Lung; Disease, Interstitial, With Fibrosis Alveolitis, Extrinsic Allergic Bird Fancier's Lung Idiopathic Interstitial Pneumonias Lung Diseases, Interstitial Idiopathic Pulmonary Fibrosis Diagnostic Test: Genetic profiling

Detailed Description:

The investigators aim to recruit participants with regular racing pigeon exposure at national (UK) and regional pigeon fancier meetings.

Consenting subjects will complete questionnaires, provide blood samples for genetic analysis and undertake lung function measurements.

Subjects will be observed, and encouraged to report referral to specialist respiratory services, and following this information will be sought on diagnosis (including supporting evidence). Where interstitial lung disease is detected this will be linked to subsequent unbiased analysis to detect potential predisposing genetic associations.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 500 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 5 Years
Official Title: British Pigeon Fanciers Genetics of Interstitial Lung Disease Study
Actual Study Start Date : January 19, 2019
Estimated Primary Completion Date : January 22, 2024
Estimated Study Completion Date : January 1, 2028

Intervention Details:
  • Diagnostic Test: Genetic profiling
    All participating subjects will undergo detailed genetic analysis, with the aim of detecting novel genetic drivers for the development of interstitial lung disease in the context of known sensitising agent (pigeon antigen)

Primary Outcome Measures :
  1. Relationship of specific genetic markers to development of interstitial lung disease [ Time Frame: 5 years ]
    Participants will be screened for MUC5B genetic profile to allow examination of MUC5B genetic profile relationship with risk of developing interstitial lung disease in this group

Biospecimen Retention:   Samples With DNA
Blood samples will be prepared for DNA analysis

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Participants in the sport of Pigeon racing

Inclusion Criteria:

  • regular exposure to racing pigeons

Exclusion Criteria:

  • Unwilling to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03747627

Layout table for location contacts
Contact: Mark Spears, PhD, FRCP +44 1324566853
Contact: Allyson Bailley, PhD +44 1786463031

Layout table for location information
United Kingdom
Royal Pigeon Racing Association Meeting Recruiting
Blackpool, United Kingdom, FY1 1HL
Contact: Mark Spears, PhD FRCP         
Sponsors and Collaborators
NHS Forth Valley
University of Leicester
University of Glasgow
Newcastle University
British Lung Foundation
British Pigeon Fanciers Medical Research
Layout table for investigator information
Principal Investigator: Mark Spears, PhD, FRCP NHS Forth Valley
Additional Information:

Layout table for additonal information
Responsible Party: Mark Spears, Dr Mark Spears, Consultant in Respiratory Medicine, NHS Forth Valley Identifier: NCT03747627    
Other Study ID Numbers: MS001
First Posted: November 20, 2018    Key Record Dates
Last Update Posted: January 18, 2020
Last Verified: January 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: Will be considered, dependent on potential for increased power

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Mark Spears, NHS Forth Valley:
Interstitial Lung Disease (ILD)
Hypersensitivity Pneumonitis
Idiopathic Pulmonary Fibrosis (IPF)
Extrinsic Allergic Alveolitis (EAA)
Bird Fancier's Lung
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Lung Diseases, Interstitial
Idiopathic Interstitial Pneumonias
Bird Fancier's Lung
Alveolitis, Extrinsic Allergic
Pathologic Processes
Respiratory Tract Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Occupational Diseases